Hyperion DeFi (NASDAQ:HYPD) Shares Down 2.2% – Should You Sell?

Hyperion DeFi, Inc. (NASDAQ:HYPD) shares dropped 2.2% during trading on Thursday . The stock traded as low as $2.60 and last traded at $2.67. Approximately 108,444 shares changed hands during trading, a decline of 52% from the average session volume of 226,529 shares. The stock had previously closed at $2.73.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on HYPD. Chardan Capital decreased their target price on Hyperion DeFi from $8.25 to $7.30 and set a “buy” rating for the company in a research report on Monday, June 8th. Cantor Fitzgerald increased their price target on Hyperion DeFi from $4.00 to $6.60 and gave the stock an “overweight” rating in a research report on Wednesday, July 1st. Weiss Ratings upgraded Hyperion DeFi from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Wednesday, June 24th. Finally, Zacks Research upgraded Hyperion DeFi from a “strong sell” rating to a “hold” rating in a research note on Tuesday, July 14th. Two research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, Hyperion DeFi has a consensus rating of “Hold” and a consensus price target of $6.95.

Hyperion DeFi Price Performance

The firm has a 50-day simple moving average of $3.00 and a 200-day simple moving average of $3.37. The firm has a market cap of $40.48 million, a P/E ratio of -0.27 and a beta of 2.53. The company has a current ratio of 1.97, a quick ratio of 1.97 and a debt-to-equity ratio of 0.12.

Insider Buying and Selling at Hyperion DeFi

In related news, insider Hyunsu Jung acquired 7,000 shares of the company’s stock in a transaction that occurred on Monday, June 1st. The shares were bought at an average price of $3.70 per share, with a total value of $25,900.00. Following the completion of the transaction, the insider directly owned 1,384,676 shares in the company, valued at $5,123,301.20. This trade represents a 0.51% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 7.50% of the stock is owned by company insiders.

Hedge Funds Weigh In On Hyperion DeFi

Large investors have recently added to or reduced their stakes in the company. Jane Street Group LLC bought a new stake in shares of Hyperion DeFi in the 4th quarter valued at about $493,000. Renaissance Technologies LLC purchased a new stake in Hyperion DeFi during the fourth quarter valued at approximately $663,000. Focus Partners Advisor Solutions LLC acquired a new stake in Hyperion DeFi in the fourth quarter valued at approximately $221,000. Geode Capital Management LLC acquired a new stake in Hyperion DeFi in the fourth quarter valued at approximately $214,000. Finally, Redwood Wealth Management Group LLC grew its holdings in Hyperion DeFi by 2.1% in the first quarter. Redwood Wealth Management Group LLC now owns 183,273 shares of the company’s stock worth $632,000 after purchasing an additional 3,690 shares during the last quarter. 25.84% of the stock is currently owned by institutional investors.

Hyperion DeFi Company Profile

Eyenovia, Inc, an ophthalmic technology company, engages in the development of therapeutics based on its proprietary microdose array print platform technology. The company's product candidates include MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; and Mydcombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis.